[144] Guidewire Software, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 filed for Guidewire Software, Inc. (GWRE) shows a proposed sale of 15,869 shares of common stock to be executed through Morgan Stanley Smith Barney on 09/16/2025 with an aggregate market value of $3,854,054.08. The shares were acquired 09/15/2025 as compensation in the form of restricted stock units and were reported as paid on 09/15/2025. The filer, John P. Mullen, also reported four prior sales in the past three months totaling 21,141 shares that generated gross proceeds of $3,297,522.31. The notice includes the filer’s representation that they are unaware of undisclosed material adverse information about the issuer.
Positive
- Disclosure compliance: Form 144 properly reports the proposed sale, acquisition date, and broker, meeting Rule 144 notice requirements
- Insider attestation: Filer represents no undisclosed material adverse information about the issuer
Negative
- Immediate sale of RSUs: Shares acquired as compensation on 09/15/2025 are being offered for sale the next day, indicating no long-term retention
- Ongoing dispositions: Multiple sales in the prior three months (total 21,141 shares) may be perceived as consistent insider selling activity
Insights
TL;DR Insider sale of recently vested RSUs and recurring monthly dispositions; moderate investor relevance.
The filing documents a planned sale of 15,869 shares valued at about $3.85 million arising from restricted stock units vested on 09/15/2025, with execution via Morgan Stanley on 09/16/2025. Recent historic sales show a pattern of periodic dispositions totaling 21,141 shares over the prior three months, producing roughly $3.30 million. For investors, these are routine insider liquidity events rather than operational disclosures; the filer affirms no undisclosed material adverse information.
TL;DR Transaction follows standard Rule 144 disclosure for insider compensation vesting and sale; governance process appears observed.
The report indicates the securities were acquired from the issuer as compensation and immediately slated for sale, consistent with executives monetizing vested awards. Use of a broker and the required attestation are present. There is no disclosure here of trading plans or Rule 10b5-1 adoption date. As disclosed, the filing meets procedural requirements but does not reveal strategic or operational implications.